Djamali Arjang, Samaniego Millie, Muth Brenda, Muehrer Rebecca, Hofmann R Michael, Pirsch John, Howard Andrew, Mourad Georges, Becker Bryan N
Department of Medicine, Nephrology Section, University of Wisconsin Madison, School of Medicine, 3034 Fish Hatchery Road, Suite B, Madison, WI 53713, USA.
Clin J Am Soc Nephrol. 2006 Jul;1(4):623-40. doi: 10.2215/CJN.01371005. Epub 2006 Mar 29.
Kidney transplantation is the treatment of choice for patients with ESRD. Despite improvements in short-term patient and graft outcomes, there has been no major improvement in long-term outcomes. The use of kidney allografts from expanded-criteria donors, polyoma virus nephropathy, underimmunosuppression, and incomplete functional recovery after rejection episodes may play a role in the lack of improvement in long-term outcomes. Other factors, including cardiovascular disease, infections, and malignancies, also shorten patient survival and therefore reduce the functional life of an allograft. There is a need for interventions that improve long-term outcomes in kidney transplant recipients. These patients are a unique subset of patients with chronic kidney disease. Therefore, interventions need to address disease progression, comorbid conditions, and patient mortality through a multifaceted approach. The Kidney Disease Outcomes Quality Initiative from the National Kidney Foundation, the European Best Practice Guidelines, and the forthcoming Kidney Disease: Improving Global Outcomes clinical practice guidelines can serve as a cornerstone of this approach. The unique aspects of chronic kidney disease in the transplant recipient require the integration of specific transplant-oriented problems into this care schema and a concrete partnership among transplant centers, community nephrologists, and primary care physicians. This article reviews the contemporary aspects of care for these patients.
肾移植是终末期肾病患者的首选治疗方法。尽管短期患者和移植物结局有所改善,但长期结局并无重大改善。使用来自扩大标准供体的肾移植、多瘤病毒肾病、免疫抑制不足以及排斥反应后功能恢复不完全,可能是长期结局缺乏改善的原因。其他因素,包括心血管疾病、感染和恶性肿瘤,也会缩短患者生存期,从而减少移植肾的功能寿命。需要采取干预措施来改善肾移植受者的长期结局。这些患者是慢性肾病患者中的一个独特亚组。因此,干预措施需要通过多方面的方法来解决疾病进展、合并症和患者死亡率问题。美国国家肾脏基金会的《肾脏病预后质量倡议》、《欧洲最佳实践指南》以及即将出台的《改善全球肾脏病预后》临床实践指南可作为这种方法的基石。移植受者慢性肾病的独特方面要求将特定的移植相关问题纳入这种护理模式,并要求移植中心、社区肾病学家和初级保健医生之间建立切实的合作关系。本文综述了这些患者护理的当代情况。